Tandem Diabetes Care, Inc. Increase (Decrease) in Accounts Receivable
Tandem Diabetes Care, Inc. (TNDM) reported Increase (Decrease) in Accounts Receivable of $3.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- Tandem Diabetes Care, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $25.76M, a 863.79% increase year-over-year.
- Tandem Diabetes Care, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$22.68M, a 309.17% decline year-over-year.
- Tandem Diabetes Care, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $42.01M, a 247.71% increase year-over-year.
- Tandem Diabetes Care, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $1.28M, a 88.92% decline year-over-year.
- Tandem Diabetes Care, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $56.81M, a 173.20% increase from fiscal 2024.
- Tandem Diabetes Care, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $20.80M.
- Tandem Diabetes Care, Inc. increase (decrease) in accounts receivable for fiscal 2023 was -$4.28M, a 154.62% decline from fiscal 2022.
- Tandem Diabetes Care, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $7.83M, a 74.73% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $25.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.08M 10-Q · filed 2026-08-06 | $45.10M derived: sum of 3 quarters · filed 2026-08-06 | $46.38M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$22.68M 10-Q · filed 2026-05-07 | $19.33M derived: sum of 2 quarters · filed 2026-05-07 | $20.62M derived: sum of 3 quarters · filed 2026-05-07 | $23.29M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $42.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $43.30M derived: sum of 2 quarters · filed 2026-02-19 | $45.97M derived: sum of 3 quarters · filed 2026-08-06 | $56.81M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.96M derived: sum of 2 quarters · filed 2026-08-06 | $14.80M 10-Q · filed 2025-11-06 | $26.88M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $13.52M 10-Q · filed 2026-08-06 | $25.60M derived: sum of 3 quarters · filed 2026-08-06 | $37.17M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $10.84M 10-Q · filed 2026-05-07 | $22.93M derived: sum of 2 quarters · filed 2026-05-07 | $34.50M derived: sum of 3 quarters · filed 2026-05-07 | $41.40M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $12.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $23.66M derived: sum of 2 quarters · filed 2026-02-19 | $30.56M derived: sum of 3 quarters · filed 2026-02-19 | $20.80M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $11.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $18.48M derived: sum of 2 quarters · filed 2025-11-06 | $8.71M 10-Q · filed 2025-11-06 | $14.31M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-06-30 | $6.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$2.86M 10-Q · filed 2025-08-06 | $2.73M derived: sum of 3 quarters · filed 2026-02-19 | $6.41M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-03-31 | -$9.77M 10-Q · filed 2025-04-30 | -$4.17M derived: sum of 2 quarters · filed 2026-02-19 | -$489.00K derived: sum of 3 quarters · filed 2026-02-19 | $8.80M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2023-12-31 | $5.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $9.28M derived: sum of 2 quarters · filed 2026-02-19 | $18.57M derived: sum of 3 quarters · filed 2026-02-19 | -$4.28M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $3.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $12.97M derived: sum of 2 quarters · filed 2024-11-06 | -$9.87M 10-Q · filed 2024-11-06 | -$6.84M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-06-30 | $9.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$13.55M 10-Q · filed 2024-08-01 | -$10.52M derived: sum of 3 quarters · filed 2025-02-26 | -$801.00K derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-03-31 | -$22.84M 10-Q · filed 2024-05-02 | -$19.81M derived: sum of 2 quarters · filed 2025-02-26 | -$10.09M derived: sum of 3 quarters · filed 2025-02-26 | $714.00K derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $12.75M derived: sum of 2 quarters · filed 2025-02-26 | $23.56M derived: sum of 3 quarters · filed 2025-02-26 | $7.83M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $9.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $20.52M derived: sum of 2 quarters · filed 2023-11-01 | $4.80M 10-Q · filed 2023-11-01 | $29.00M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $10.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$4.92M 10-Q · filed 2023-08-03 | $19.29M derived: sum of 3 quarters · filed 2024-02-21 | $27.10M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | -$15.73M 10-Q · filed 2023-05-03 | $8.48M derived: sum of 2 quarters · filed 2024-02-21 | $16.30M derived: sum of 3 quarters · filed 2024-02-21 | $23.64M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $24.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $32.03M derived: sum of 2 quarters · filed 2024-02-21 | $39.37M derived: sum of 3 quarters · filed 2024-02-21 | $30.98M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $7.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $15.16M derived: sum of 2 quarters · filed 2022-11-02 | $6.77M 10-Q · filed 2022-11-02 | $37.79M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | $7.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$1.05M 10-Q · filed 2022-08-03 | $29.97M derived: sum of 3 quarters · filed 2023-02-22 | $37.74M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | -$8.39M 10-Q · filed 2022-05-04 | $22.63M derived: sum of 2 quarters · filed 2023-02-22 | $30.40M derived: sum of 3 quarters · filed 2023-02-22 | $22.16M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | $31.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $38.79M derived: sum of 2 quarters · filed 2023-02-22 | $30.55M derived: sum of 3 quarters · filed 2023-02-22 | $38.84M 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $7.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$472.00K derived: sum of 2 quarters · filed 2021-11-03 | $7.82M 10-Q · filed 2021-11-03 | $9.93M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-06-30 | -$8.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $50.00K 10-Q · filed 2021-08-04 | $2.16M derived: sum of 3 quarters · filed 2022-02-22 | -$240.00K derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-03-31 | $8.29M 10-Q · filed 2021-05-05 | $10.40M derived: sum of 2 quarters · filed 2022-02-22 | $8.00M derived: sum of 3 quarters · filed 2022-02-22 | $23.81M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2019-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$290.00K derived: sum of 2 quarters · filed 2022-02-22 | $15.52M derived: sum of 3 quarters · filed 2022-02-22 | $13.70M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | -$2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $13.41M derived: sum of 2 quarters · filed 2020-11-05 | $11.59M 10-Q · filed 2020-11-05 | $25.52M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | $15.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $13.99M 10-Q · filed 2020-07-30 | $27.92M derived: sum of 3 quarters · filed 2021-02-24 | $35.97M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | -$1.82M 10-Q · filed 2020-04-30 | $12.11M derived: sum of 2 quarters · filed 2021-02-24 | $20.16M derived: sum of 3 quarters · filed 2021-02-24 | $21.68M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $13.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $21.98M derived: sum of 2 quarters · filed 2021-02-24 | $23.50M derived: sum of 3 quarters · filed 2021-02-24 | $15.85M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $8.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $9.57M derived: sum of 2 quarters · filed 2019-11-04 | $1.91M 10-Q · filed 2019-11-04 | $12.29M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$6.13M 10-Q · filed 2019-08-01 | $4.24M derived: sum of 3 quarters · filed 2020-02-24 | $6.04M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | -$7.66M 10-Q · filed 2019-04-30 | $2.71M derived: sum of 2 quarters · filed 2020-02-24 | $4.51M derived: sum of 3 quarters · filed 2020-02-24 | $5.97M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $10.37M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $12.17M derived: sum of 2 quarters · filed 2020-02-24 | $13.62M derived: sum of 3 quarters · filed 2020-02-24 | $10.45M 10-K · filed 2020-02-24 | |||
| 2017-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $3.25M derived: sum of 2 quarters · filed 2018-11-01 | $73.00K 10-Q · filed 2018-11-01 | $3.01M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | -$1.73M 10-Q · filed 2018-07-30 | $1.21M derived: sum of 3 quarters · filed 2019-02-26 | $51.00K derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | -$3.18M 10-Q · filed 2018-04-26 | -$238.00K derived: sum of 2 quarters · filed 2019-02-26 | -$1.40M derived: sum of 3 quarters · filed 2019-02-26 | -$839.00K derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.78M derived: sum of 2 quarters · filed 2019-02-26 | $2.34M derived: sum of 3 quarters · filed 2019-02-26 | -$2.25M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | -$1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$601.00K derived: sum of 2 quarters · filed 2017-10-26 | -$5.19M 10-Q · filed 2017-10-26 | $1.94M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $562.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | -$4.03M 10-Q · filed 2017-07-27 | $3.10M derived: sum of 3 quarters · filed 2018-03-01 | $2.72M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | -$4.59M 10-Q · filed 2017-04-27 | $2.54M derived: sum of 2 quarters · filed 2018-03-01 | $2.16M derived: sum of 3 quarters · filed 2018-03-01 | $4.34M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $7.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $6.75M derived: sum of 2 quarters · filed 2018-03-01 | $8.93M derived: sum of 3 quarters · filed 2018-03-01 | $6.47M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | -$374.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $1.80M derived: sum of 2 quarters · filed 2016-11-01 | -$653.00K 10-Q · filed 2016-11-01 | $1.24M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-06-30 | $2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$279.00K 10-Q · filed 2016-07-28 | $1.61M derived: sum of 3 quarters · filed 2017-03-08 | $3.10M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-03-31 | -$2.46M 10-Q · filed 2016-04-28 | -$565.00K derived: sum of 2 quarters · filed 2017-03-08 | $919.00K derived: sum of 3 quarters · filed 2017-03-08 | $1.91M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2014-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $3.38M derived: sum of 2 quarters · filed 2017-03-08 | $4.36M derived: sum of 3 quarters · filed 2017-03-08 | $2.54M 10-K · filed 2017-03-08 | |||
| 2014-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $2.47M derived: sum of 2 quarters · filed 2015-10-29 | $649.00K 10-Q · filed 2015-10-29 | $649.07K 10-Q · filed 2014-11-06 | $1.91M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | $986.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$835.00K 10-Q · filed 2015-07-30 | -$835.30K 10-Q · filed 2014-07-31 | $426.99K derived: sum of 3 quarters · filed 2016-02-24 | $1.91M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | -$1.82M 10-Q · filed 2015-04-30 | -$1.82M 10-Q · filed 2014-05-06 | -$559.01K derived: sum of 2 quarters · filed 2016-02-24 | $923.06K derived: sum of 3 quarters · filed 2016-02-24 | $1.49M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2013-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $2.74M derived: sum of 2 quarters · filed 2016-02-24 | $3.31M derived: sum of 3 quarters · filed 2016-02-24 | $3.16M 10-K · filed 2016-02-24 | |||
| 2013-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $2.05M derived: sum of 2 quarters · filed 2014-11-06 | $1.90M 10-Q · filed 2014-11-06 | ||||
| 2013-06-30 | $568.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $416.94K 10-Q · filed 2014-07-31 | |||||
| 2013-03-31 | -$151.75K 10-Q · filed 2014-05-06 | ||||||
| 2012-12-31 | $2.46M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |